These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22564108)

  • 1. Totally drug-resistant tuberculosis in India: who let the djinn out?
    Udwadia ZF
    Respirology; 2012 Jul; 17(5):741-2. PubMed ID: 22564108
    [No Abstract]   [Full Text] [Related]  

  • 2. Multi drug resistant tuberculosis.
    Dey AB; Nagarkar K
    Trop Gastroenterol; 1995; 16(2):92-100. PubMed ID: 8644369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving technical assistance for drug-resistant tuberculosis.
    Furin J
    Int J Tuberc Lung Dis; 2011 Mar; 15(3):421-2. PubMed ID: 21333116
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of multidrug-resistant tuberculosis: definition of the outcome 'failure'.
    Chiang CY; Van Deun A; Trébucq A; Heldal E; Caminero JA; Aït-Khaled N
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):4-5. PubMed ID: 21276289
    [No Abstract]   [Full Text] [Related]  

  • 5. Managing drug-resistant tuberculosis: experiences from India.
    Katoch VM
    Expert Rev Anti Infect Ther; 2010 May; 8(5):493-6. PubMed ID: 20455676
    [No Abstract]   [Full Text] [Related]  

  • 6. Control of tuberculosis in India.
    Mohapatra PR
    Lancet; 2003 Oct; 362(9391):1243. PubMed ID: 14568763
    [No Abstract]   [Full Text] [Related]  

  • 7. The most recent report from the World Health Organization found that, worldwide, approximately 5% of new tuberculosis cases are caused by multidrug-resistant strains (MDR TB).
    Denholm J
    J Travel Med; 2010; 17(3):216. PubMed ID: 20536899
    [No Abstract]   [Full Text] [Related]  

  • 8. Public health. Responding to market failures in tuberculosis control.
    Gupta R; Kim JY; Espinal MA; Caudron JM; Pecoul B; Farmer PE; Raviglione MC
    Science; 2001 Aug; 293(5532):1049-51. PubMed ID: 11463877
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tuberculosis: antibiotic resistances, more than ever a menace].
    Nau JY
    Rev Med Suisse; 2012 Sep; 8(353):1746-7. PubMed ID: 23029990
    [No Abstract]   [Full Text] [Related]  

  • 10. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slow elimination of multidrug-resistant tuberculosis.
    Dye C; Williams BG
    Sci Transl Med; 2009 Oct; 1(3):3ra8. PubMed ID: 20368167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TB "hot zones" emerging.
    Public Health Rep; 1998; 113(2):107. PubMed ID: 9719808
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug resistance to the first line of antitubercular regimen (a preliminary report).
    Varaiya A; Gogate A
    Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescriptions for tuberculosis treatment: get it right the first time.
    Pinto L; Udwadia Z
    Int J Tuberc Lung Dis; 2011 Apr; 15(4):567; author reply 567-8. PubMed ID: 21396223
    [No Abstract]   [Full Text] [Related]  

  • 15. The unsurprising story of MDR-TB resistance in India.
    Babu GR; Laxminarayan R
    Tuberculosis (Edinb); 2012 Jul; 92(4):301-6. PubMed ID: 22504008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of extensively drug-resistant tuberculosis.
    Khurana AK; Mohapatra PR
    Eur Respir J; 2009 Sep; 34(3):780; author reply 780-1. PubMed ID: 19720817
    [No Abstract]   [Full Text] [Related]  

  • 17. MDR- and XDR-TB among suspected drug-resistant TB patients in a tertiary care hospital in India.
    James P; Gupta R; Christopher DJ; Thankagunam B; Veeraraghavan B
    Clin Respir J; 2011 Jan; 5(1):19-25. PubMed ID: 21159137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug-resistant tuberculosis: standardized or individualized treatment? The question has already been answered.
    Laniado-Laborín R
    Expert Rev Respir Med; 2010 Apr; 4(2):143-6. PubMed ID: 20406077
    [No Abstract]   [Full Text] [Related]  

  • 19. XDR-TB danger ahead.
    Behera D
    Indian J Tuberc; 2007 Apr; 54(2):99; author reply 99. PubMed ID: 17577914
    [No Abstract]   [Full Text] [Related]  

  • 20. XDR-TB danger ahead.
    Chauhan LS
    Indian J Tuberc; 2007 Apr; 54(2):99; author reply 99. PubMed ID: 17575682
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.